Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection

Figure 3

Model of the molecular mechanism in retinal inflammation. IL-6 family ligands induce STAT3 activation, which promotes excessive UPS-mediated rhodopsin protein degradation and subsequent visual dysfunction.